The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
Open accessAbstract
Advanced glycation end-products (AGEs) constitute a non-homogenous, chemically diverse group of compounds formed either exogeneously or endogeneously on the course of various pathways in the human body. In general, they are formed non-enzymatically by condensation between carbonyl groups of reducing sugars and free amine groups of nucleic acids, proteins, or lipids, followed by further rearrangements yielding stable, irreversible end-products. In the last decades, AGEs have aroused the interest of the scientific community due to the increasing evidence of their involvement in many pathophysiological processes and diseases, such as diabetes, cancer, cardiovascular, neurodegenerative diseases, and even infection with the SARS-CoV-2 virus. They are recognized by several cellular receptors and trigger many signaling pathways related to inflammation and oxidative stress. Despite many experimental research outcomes published recently, the complexity of their engagement in human physiology and pathophysiological states requires further elucidation. This review focuses on the receptors of AGEs, especially on the structural aspects of receptor–ligand interaction, and the diseases in which AGEs are involved. It also aims to present AGE classification in subgroups and to describe the basic processes leading to both exogeneous and endogeneous AGE formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives
Chiappalupi, S., Salvadori, L., Vukašinović, A., Donato, R., Sorci, G., & Riuzzi, F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119251 · Cited by 40
Taguchi, K., Fukami, K., Elias, B. C., & Brooks, C. R. (2021) · Toxins · doi:10.3390/toxins13050361 · Cited by 40
Genome Organization of Human 48-kDa Oligosaccharyltransferase (DDOST)
Yamagata, T., Tsuru, T., Momoi, M. Y., Suwa, K., Nozaki, Y., Mukasa, T., Ohashi, H., Fukushima, Y., & Momoi, T. (1997) · Genomics · doi:10.1006/geno.1997.4966 · Cited by 39
Low‐Molecular Weight Advanced Glycation End Products: Markers of Tissue AGE Accumulation and More?
Thomas, M. C., Forbes, J. M., MacIsaac, R. J., Jerums, G., & Cooper, M. E. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.073 · Cited by 39
Stirban, A., Heinemann, L., Complications, D. E. A. D., & Senior Scientific Consultant, P. (2014) · European Endocrinology · doi:10.17925/ee.2014.10.02.106 · Cited by 38
Studies of advanced glycation end products and oxidation biomarkers for type 2 diabetes
Chiu, C., Rabbani, N., Rowan, S., Chang, M., Sawyer, S. J., Hu, F. B., Willett, W. C., Thornalley, P. J., Anwar, A., Bar, L. K., et al. (2018) · BioFactors · doi:10.1002/biof.1423 · Cited by 38
Short-term effects of dietary advanced glycation end products in rats
Poulsen, M. W., Andersen, J. M., Hedegaard, R. V., Madsen, A. N., Krath, B. N., Monošík, R., Bak, M. J., Nielsen, J., Holst, B., Skibsted, L. H., et al. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515004833 · Cited by 37
Khajuria, D. K., Soliman, M., Elfar, J. C., Lewis, G. S., Abraham, T., Kamal, F., & Elbarbary, R. A. (2020) · Bone · doi:10.1016/j.bone.2020.115436 · Cited by 37
The Role of Advanced Glycation End-Products in Cancer Disparity
Turner, D. P. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.08.001 · Cited by 36
Plasma levels of soluble receptor for advanced glycation end products in Alzheimer's disease
Xu, X., Deng, C., Wang, J., Deng, X., Xiao, Q., Li, Y., He, Q., Fan, W.-H., Quan, F., Zhu, Y.-P., et al. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1193861 · Cited by 35
Dozio, E., Sitzia, C., Pistelli, L., Cardani, R., Rigolini, R., Ranucci, M., & Romanelli, M. M. C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113785 · Cited by 34
Botros, N., Sluik, D., van Waateringe, R. P., de Vries, J. H. M., Geelen, A., & Feskens, E. J. M. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2892 · Cited by 33
Khan, H., Khan, M. S., & Ahmad, S. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27170 · Cited by 33
Lee, K. J., Yoo, J. W., Kim, Y. K., Choi, J. H., Ha, T., & Gil, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.182 · Cited by 32
Mirlohi, M. S., Yaghooti, H., Shirali, S., Asnafi, A. A., & Olapour, S. (2018) · Annals of Hematology · doi:10.1007/s00277-017-3223-3 · Cited by 32
Lee, H.-W., Gu, M. J., Kim, Y., Lee, J., Lee, S., Choi, I., & Ha, S. K. (2021) · Antioxidants · doi:10.3390/antiox10091486 · Cited by 31
Băbțan, A.-M., Ilea, A., Boşca, A. B., Crişan, M., Petrescu, N. B., Collino, M., Sainz, R. M., Gerlach, J. Q., & Câmpian, R. S. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0448 · Cited by 30
Mariño, L., Ramis, R., Casasnovas, R., Ortega‐Castro, J., Vilanova, B., Frau, J., & Adrover, M. (2020) · Chemical Science · doi:10.1039/d0sc00906g · Cited by 29
Nakajou, K., Horiuchi, S., Sakai, M., Hirata, K., Tanaka, M. R., Takeya, M., Kai, T., & Otagiri, M. (2005) · The Journal of Biochemistry · doi:10.1093/jb/mvi071 · Cited by 28
Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?
Zhuang, A., & Forbes, J. M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9693-z · Cited by 28
Pereira, E. N. G. D. S., Paula, D. P., de Araujo, B. P., da Fonseca, M. D. J. M., Diniz, M. D. F. H. S., Daliry, A., & Griep, R. H. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4913 · Cited by 28
Increased Protein Glycation in Cirrhosis and Therapeutic Strategies to Prevent It
AHMED, N., LÜTHEN, R., HÄUSSINGER, D., ŠEBEKOVÁ, K., SCHINZEL, R., VOELKER, W., HEIDLAND, A., & THORNALLEY, P. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.083 · Cited by 26
Urinary excretion of advanced glycation end products in dogs and cats
Palaseweenun, P., Hagen-Plantinga, E. A., Schonewille, J. T., Koop, G., Butré, C. I., Jonathan, M. C., Wierenga, P. A., & Hendriks, W. H. (2020) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13347 · Cited by 26
Endocytosis of Advanced Glycation End-Products in Bovine Choriocapillaris Endothelial Cells
Li, R., McCourt, P., Schledzewski, K., Goerdt, S., Moldenhauer, G., Liu, X., Smedsrød, B. H., & Sørensen, K. K. (2009) · Microcirculation · doi:10.1080/10739680903133185 · Cited by 25
Petriv, N., Neubert, L., Vatashchuk, M., Timrott, K., Suo, H., Hochnadel, I., Huber, R., Petzold, C., Hrushchenko, A. O., Yatsenko, A. S., et al. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1874159 · Cited by 25
Cepas, V., Manig, F., Mayo, J. C., Hellwig, M., Collotta, D., Sanmartino, V., Carrocera, R., Collino, M., Henle, T., & Sainz, R. M. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9912240 · Cited by 25
Advanced Glycation End Products as Environmental Risk Factors for the Development of Type 1 Diabetes
Yap, F. Y. T., Kantharidis, P., Coughlan, M. T., Slattery, R. M., & Forbes, J. M. (2012) · Current Drug Targets · doi:10.2174/138945012799499758 · Cited by 24
Pandey, M. S., & Weigel, P. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565846 · Cited by 23
Age-Dependent Expression of Advanced Glycation End Product Receptor Genes in the Human Heart
Caßelmann, C. A., Reimann, A., Friedrich, I., Schubert, A., Silber, R., & Simm, A. (2004) · Gerontology · doi:10.1159/000076770 · Cited by 22
A fragment‐based approach to discovery of Receptor for Advanced Glycation End products inhibitors
Kozlyuk, N., Gilston, B. A., Salay, L. E., Gogliotti, R. D., Christov, P. P., Kim, K., Ovee, M., Waterson, A. G., & Chazin, W. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26162 · Cited by 21
Association Between Early Markers of Renal Injury and Type 2 Diabetic Peripheral Neuropathy
Yang, Z., Lou, X., Zhang, J., Nie, R., Liu, J., Tu, P., & Duan, P. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s335283 · Cited by 21
Adverse effects of advanced glycation end products on embryonal development.
Lin, H., Noguchi, S., Kamada, Y., Sasaki, A., 松田, 美., Shimizu, K., Hiramatsu, Y., & Nakatsuka, M. (2008) · PubMed · doi:10.18926/amo/30960 · Cited by 15
Recent developments in in-vitro assessment of advanced glycation end products
Serin, Y., Akbulut, G., Uğur, H., & Yaman, M. (2021) · Current Opinion in Food Science · doi:10.1016/j.cofs.2021.03.011 · Cited by 15
Ying, L., Shen, Y., Zhang, Y., Wang, Y., Liu, Y., Yin, J., Wang, Y., Yin, J., Zhu, W., Bao, Y., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.09.005 · Cited by 14
Nakano, S., Sugihara, M., Yamada, R., Katayanagi, K., & Tate, S. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.02.003 · Cited by 12
Armando Rojas, R., Schneider, I., Lindner, C., González, I., & Morales, M. A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i19.2270 · Cited by 11
Kobori, T., Ganesh, D., Kumano-Kuramochi, M., Torigoe, K., & Machida, S. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114018 · Cited by 10
Ketosylamin‐Umlagerung bei der Umsetzung von D ‐threo‐Pentulose ( D ‐Xylulose) mit α‐Aminosäuren
Heyns, K., & Beilfuß, W. (1970) · Chemische Berichte · doi:10.1002/cber.19701030925 · Cited by 9
Laudenslager, M., Lazo, M., Wang, D., Selvin, E., Chen, P., Pankow, J. S., & Clark, J. M. (2021) · Digestive and Liver Disease · doi:10.1016/j.dld.2021.02.005 · Cited by 8
Safwat, N. A., & Kenny, M. A. (2018) · Pediatric Research · doi:10.1038/s41390-018-0221-7 · Cited by 7
Abdel-Razik, A., Shabana, W., Nakib, A. M. E., Abdelsalam, M., Abdelwahab, A., Hasan, A. S., Elzehery, R. R., Elhelaly, R. M., Fathy, A. A., Mostafa, S. A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.662431 · Cited by 7
Varikasuvu, S. R., Varshney, S., & Sulekar, H. (2021) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000792932.01773.d5 · Cited by 7
Ghosh, S., Kapoor, D., Vijayvergiya, R., Sangwan, S., Wangkheimayum, S., Mehta, S., & Dhawan, V. (2021) · World Journal of Cardiology · doi:10.4330/wjc.v13.i5.130 · Cited by 3
Cited by
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications
Caturano, A., D’Angelo, M., Mormone, A., Russo, V., Mollica, M. P., Salvatore, T., Galiero, R., Rinaldi, L., Vetrano, E., Marfella, R., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080420 · Cited by 579
El Hosry, L., Elias, V., Chamoun, V., Halawi, M., Cayot, P., Nehme, A., & Bou-Maroun, E. (2025) · Foods · doi:10.3390/foods14111881 · Cited by 400
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
Yan, L., Wang, J., Cai, X., Liou, Y., Shen, H., Hao, J., Huang, C., Luo, G., & He, W. (2024) · MedComm · doi:10.1002/mco2.658 · Cited by 343
Inflammation and nutrition: friend or foe?
Stumpf, F., Keller, B., Gressies, C., & Schuetz, P. (2023) · Nutrients · doi:10.3390/nu15051159 · Cited by 213
Hong, B., Bea, S., Ko, H. Y., Kim, W. J., Cho, Y. M., & Shin, J.-Y. (2024) · Annals of Internal Medicine · doi:10.7326/m23-3220 · Cited by 33
Metadata
- Authors
- Twarda-Clapa, A., Olczak, A., Białkowska, A. M., & Koziołkiewicz, M.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-04-12
- Volume
- 11
- Issue
- 8
- Pages
- 1312
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4223542076
- Cited by
- 746
- References
- 243
- FWCI
- 73.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.